Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELAFIBRANOR vs ELAGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELAFIBRANOR vs ELAGOLIX: Safety Overview

Metric ELAFIBRANOR ELAGOLIX
Total FAERS Reports 356 3,582
Deaths Reported 4 5
Death Rate 1.1% 0.1%
Hospitalizations 19 299
Average Patient Age 59.8 yrs 34.6 yrs
% Female Patients 96.1% 99.7%
FDA Approval Date Jun 10, 2024 Jul 23, 2018
Manufacturer Ipsen Biopharmaceuticals, Inc. AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription